| Function of Macrophages in Disease: Current Understanding on Molecular Mechanisms C Zhang, M Yang, AC Ericsson Frontiers in Immunology 12, 620510, 2021 | 162 | 2021 |
| Antimicrobial peptides: potential application in liver cancer C Zhang, M Yang, AC Ericsson Frontiers in microbiology 10, 1257, 2019 | 78 | 2019 |
| Synergizing sunitinib and radiofrequency ablation to treat hepatocellular cancer by triggering the antitumor immune response X Qi, M Yang, L Ma, M Sauer, D Avella, JT Kaifi, J Bryan, K Cheng, ... Journal for immunotherapy of cancer 8 (2), 2020 | 75 | 2020 |
| Current Options and Future Directions for NAFLD and NASH Treatment C Zhang, M Yang International Journal of Molecular Sciences 22 (14), 7571, 2021 | 70 | 2021 |
| Antimicrobial Peptides: From Design to Clinical Application C Zhang, M Yang Antibiotics 11 (3), 349, 2022 | 69 | 2022 |
| The Related Metabolic Diseases and Treatments of Obesity M Yang, S Liu, C Zhang Healthcare 10 (9), 1616, 2022 | 53 | 2022 |
| Understanding genetic control of root system architecture in soybean: Insights into the genetic basis of lateral root number SJ Prince, B Valliyodan, H Ye, M Yang, S Tai, W Hu, M Murphy, ... Plant, cell & environment 42 (1), 212-229, 2019 | 52 | 2019 |
| Beta-defensin derived cationic antimicrobial peptides with potent killing activity against gram negative and gram positive bacteria M Yang, C Zhang, MZ Zhang, S Zhang BMC microbiology 18, 1-14, 2018 | 48 | 2018 |
| The role of liver sinusoidal endothelial cells in cancer liver metastasis M Yang, C Zhang American Journal of Cancer Research 11 (5), 1845, 2021 | 46 | 2021 |
| The potential gut microbiota mediated treatment options for liver cancer C Zhang, M Yang, AC Ericsson Frontiers in Oncology 10, 2214, 2020 | 46 | 2020 |
| Hepatocellular carcinoma and obesity, type 2 diabetes mellitus, cardiovascular disease: causing factors, molecular links, and treatment options C Zhang, S Liu, M Yang Frontiers in Endocrinology 12, 808526, 2021 | 44 | 2021 |
| Structure-function analysis of Avian β-defensin-6 and β-defensin-12: role of charge and disulfide bridges M Yang, C Zhang, X Zhang, MZ Zhang, GE Rottinghaus, S Zhang BMC microbiology 16, 1-18, 2016 | 43 | 2016 |
| Western diet contributes to the pathogenesis of non-alcoholic steatohepatitis in male mice via remodeling gut microbiota and increasing production of 2-oleoylglycerol M Yang, X Qi, N Li, JT Kaifi, S Chen, AA Wheeler, ET Kimchi, AC Ericsson, ... Nature Communications 14, 228, 2023 | 39 | 2023 |
| G protein-coupled receptors as potential targets for nonalcoholic fatty liver disease treatment M Yang, CY Zhang World Journal of Gastroenterology 27 (8), 677, 2021 | 29 | 2021 |
| The Emerging Factors and Treatment Options for NAFLD-Related Hepatocellular Carcinoma C Zhang, M Yang Cancers 13 (15), 3740, 2021 | 27 | 2021 |
| Gut microbiota mediated molecular events and therapy in liver diseases X Qi, M Yang, J Stenberg, R Dey, L Fogwe, MS Alam, ET Kimchi, ... World Journal of Gastroenterology 26 (48), 7603, 2020 | 26 | 2020 |
| The role and potential application of antimicrobial peptides in autoimmune diseases C Zhang, M Yang Frontiers in immunology 11, 859, 2020 | 26 | 2020 |
| Novel synthetic analogues of avian β-defensin-12: the role of charge, hydrophobicity, and disulfide bridges in biological functions M Yang, C Zhang, MZ Zhang, S Zhang BMC microbiology 17, 1-14, 2017 | 26 | 2017 |
| Treatment of liver fibrosis: Past, current, and future CY Zhang, S Liu, M Yang World Journal of Hepatology 15 (6), 755, 2023 | 25 | 2023 |
| Antioxidant and anti-inflammatory agents in chronic liver diseases: Molecular mechanisms and therapy CY Zhang, S Liu, M Yang World Journal of Hepatology 15 (2), 180, 2023 | 22 | 2023 |
